Erythropoiesis stimulating agents and clinical outcomes of invasive breast cancer patients receiving cytotoxic chemotherapy.

about

The effects of erythropoiesis-stimulating agents on the short-term and long-term survivals in metastatic breast cancer patients receiving chemotherapy: a SEER population-based study.

P2860

Q41492136-D15C797E-FB86-4CD5-B334-70C3C793C567

P2860

Erythropoiesis stimulating agents and clinical outcomes of invasive breast cancer patients receiving cytotoxic chemotherapy.

Item

http://www.wikidata.org/entity/Q51049616

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh

2014年學術文章

@zh-hant

name

Erythropoiesis stimulating age ...... eiving cytotoxic chemotherapy.

@en

Erythropoiesis stimulating age ...... eiving cytotoxic chemotherapy.

@nl

type

Item

label

Erythropoiesis stimulating age ...... eiving cytotoxic chemotherapy.

@en

Erythropoiesis stimulating age ...... eiving cytotoxic chemotherapy.

@nl

prefLabel

Erythropoiesis stimulating age ...... eiving cytotoxic chemotherapy.

@en

Erythropoiesis stimulating age ...... eiving cytotoxic chemotherapy.

@nl

P1476

Erythropoiesis stimulating age ...... eiving cytotoxic chemotherapy.

@en

P2093

Bingshan Li

http://www.w3.org/2001/XMLSchema#string

Hushan Yang

http://www.w3.org/2001/XMLSchema#string

Jesse Civan

http://www.w3.org/2001/XMLSchema#string

Jinliang Xing

http://www.w3.org/2001/XMLSchema#string

Juan P Palazzo

http://www.w3.org/2001/XMLSchema#string

Massimo Cristofanilli

http://www.w3.org/2001/XMLSchema#string

Terry Hyslop

http://www.w3.org/2001/XMLSchema#string

Tiffany Avery

http://www.w3.org/2001/XMLSchema#string

Yinzhi Lai

http://www.w3.org/2001/XMLSchema#string

Zhong Ye

http://www.w3.org/2001/XMLSchema#string

P2860

Recombinant human erythropoietin antagonizes trastuzumab treatment of breast cancer cells via Jak2-mediated Src activation and PTEN inactivation

Nonparametric Estimation from Incomplete Observations

Prevalence and management of cancer-related anaemia, iron deficiency and the specific role of i.v. iron

Improved estimates of cancer-specific survival rates from population-based data

Recombinant human erythropoietins and cancer patients: updated meta-analysis of 57 studies including 9353 patients.

Darbepoetin alfa for treating chemotherapy-induced anemia in patients with a baseline hemoglobin level < 10 g/dL versus > or = 10 g/dL: an exploratory analysis from a randomized, double-blind, active-controlled trial

Evaluating overall survival and competing risks of death in patients with localized renal cell carcinoma using a comprehensive nomogram

Erythropoiesis-stimulating agents in oncology: a study-level meta-analysis of survival and other safety outcomes.

Association between pharmaceutical support and basic science research on erythropoiesis-stimulating agents

Epoetin treatment of anemia associated with cancer therapy: a systematic review and meta-analysis of controlled clinical trials.

P2888

s10549-014-3152-y

P304

175-185

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10549-014-3152-Y

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

148

http://www.w3.org/2001/XMLSchema#string

P50

Ronald E. Myers

P577

2014-09-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25261294

http://www.w3.org/2001/XMLSchema#string

P921

cytotoxicity

Erythropoiesis stimulating agents and clinical outcomes of invasive breast cancer patients receiving cytotoxic chemotherapy.

about

P2860

P2860

Erythropoiesis stimulating agents and clinical outcomes of invasive breast cancer patients receiving cytotoxic chemotherapy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921